129 related articles for article (PubMed ID: 23955613)
1. Is neuroinflammation involved in the development of dementia in patients with Parkinson's disease?
Song IU; Kim YD; Cho HJ; Chung SW
Intern Med; 2013; 52(16):1787-92. PubMed ID: 23955613
[TBL] [Abstract][Full Text] [Related]
2. Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals.
Song IU; Kim JS; Chung SW; Lee KS
Eur Neurol; 2009; 62(2):99-104. PubMed ID: 19521085
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease.
Baran A; Bulut M; Kaya MC; Demirpençe Ö; Sevim B; Akıl E; Varol S
Neurol Sci; 2019 Jan; 40(1):167-173. PubMed ID: 30353300
[TBL] [Abstract][Full Text] [Related]
4. Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
Wang T; Yuan F; Chen Z; Zhu S; Chang Z; Yang W; Deng B; Que R; Cao P; Chao Y; Chan L; Pan Y; Wang Y; Xu L; Lyu Q; Chan P; Yenari MA; Tan EK; Wang Q
Aging (Albany NY); 2020 Aug; 12(15):15682-15704. PubMed ID: 32805719
[TBL] [Abstract][Full Text] [Related]
5. Serum hs-CRP levels are increased in de Novo Parkinson's disease independently from age of onset.
Song IU; Cho HJ; Kim JS; Park IS; Lee KS
Eur Neurol; 2014; 72(5-6):285-9. PubMed ID: 25323302
[TBL] [Abstract][Full Text] [Related]
6. Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson's disease.
Song IU; Chung SW; Kim JS; Lee KS
Neurol Sci; 2011 Feb; 32(1):31-4. PubMed ID: 20532580
[TBL] [Abstract][Full Text] [Related]
7. Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease.
Umemura A; Oeda T; Yamamoto K; Tomita S; Kohsaka M; Park K; Sugiyama H; Sawada H
PLoS One; 2015; 10(8):e0136722. PubMed ID: 26308525
[TBL] [Abstract][Full Text] [Related]
8. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease.
Andican G; Konukoglu D; Bozluolcay M; Bayülkem K; Firtiına S; Burcak G
Acta Neurol Belg; 2012 Jun; 112(2):155-9. PubMed ID: 22426659
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.
Lindqvist D; Hall S; Surova Y; Nielsen HM; Janelidze S; Brundin L; Hansson O
Brain Behav Immun; 2013 Oct; 33():183-9. PubMed ID: 23911592
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the hs-CRP as non-specific biomarker and Alzheimer's disease according to aging process.
Song IU; Chung SW; Kim YD; Maeng LS
Int J Med Sci; 2015; 12(8):613-7. PubMed ID: 26283879
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein and fibrinogen in non-obstructive coronary artery disease as related to depressive symptoms and anxiety: findings from the TweeSteden Mild Stenosis Study (TWIST).
Mommersteeg PM; Meeuwis SH; Denollet J; Widdershoven JW; Aarnoudse W; Westerhuis BL; Kop WJ
J Psychosom Res; 2014 Nov; 77(5):426-9. PubMed ID: 25307791
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD).
Song IU; Kim JS; Park IS; Kim YD; Cho HJ; Chung SW; Lee KS
Arch Gerontol Geriatr; 2013; 57(3):288-91. PubMed ID: 23706974
[TBL] [Abstract][Full Text] [Related]
13. QEEG indices are associated with inflammatory and metabolic risk factors in Parkinson's disease dementia: An observational study.
Liu H; Deng B; Zhou H; Wu Z; Chen Y; Weng G; Zhu S; Xu J; Wang H; Zhou Z; Tan EK; Wang Q
EClinicalMedicine; 2022 Oct; 52():101615. PubMed ID: 36034410
[TBL] [Abstract][Full Text] [Related]
14. Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males.
Sarangi R; Padhi S; Mohapatra S; Swain S; Padhy RK; Mandal MK; Patro SK; Kumar S
Diabetes Metab Syndr; 2012; 6(1):9-14. PubMed ID: 23014248
[TBL] [Abstract][Full Text] [Related]
15. Tau protein, beta-amyloid₁₋₄₂ and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia.
Vranová HP; Hényková E; Kaiserová M; Menšíková K; Vaštík M; Mareš J; Hluštík P; Zapletalová J; Strnad M; Stejskal D; Kaňovský P
J Neurol Sci; 2014 Aug; 343(1-2):120-4. PubMed ID: 24928081
[TBL] [Abstract][Full Text] [Related]
16. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease.
Akıl E; Bulut A; Kaplan İ; Özdemir HH; Arslan D; Aluçlu MU
Neurol Sci; 2015 Mar; 36(3):423-8. PubMed ID: 25288159
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
[TBL] [Abstract][Full Text] [Related]
18. Higher vitamin B12 level at Parkinson's disease diagnosis is associated with lower risk of future dementia.
McCarter SJ; Stang C; Turcano P; Mielke MM; Ali F; Bower JH; Savica R
Parkinsonism Relat Disord; 2020 Apr; 73():19-22. PubMed ID: 32203914
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
Huang W; Chen QW; Lei H; Deng W; Ke DZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
[TBL] [Abstract][Full Text] [Related]
20. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
